Rady Children's Specialists of San Diego
Mount Sinai School of Medicine
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Dermatology, Pediatric Dermatology, Pediatrics
Dr. Lawrence Eichenfield is chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego, as well as vice chair of the Department of Dermatology and a professor of dermatology and pediatrics at UC San Diego School of Medicine.
Dr. Eichenfield earned his medical degree from Mount Sinai School of Medicine in New York, was a pediatric resident and chief resident at Children's Hospital of Philadelphia, and completed dermatology training at the hospital of the University of Pennsylvania. He is board certified in pediatrics, dermatology and pediatric dermatology.
Dr. Eichenfield's clinical interests include atopic dermatitis, acne, psoriasis, vascular legions including port wine stains and hemangiomas, neonatal dermatology, laser surgery, nevi and skin signs of systemic disease. He has authored more than 300 journal articles, chapters, abstracts and books on these topics and serves on the editorial boards of multiple journals and periodicals. Along with being editor-in-chief of Pediatric Dermatology, he has served as senior editor for "Neonatal and Infant Dermatology," published by Elsevier, and "The Eczemas," published by Summit Communications.
He has been honored as a member of the Alpha Omega Alpha Honor Society during medical school, and as a recipient of the Benjamin Ritter Award at Children's Hospital of Philadelphia and excellence in teaching awards from UC San Diego Pediatrics, UC San Diego Dermatology and Rady Children's.
Dr. Eichenfield is past president of the Society for Pediatric Dermatology, has served on the board of the American Academy of Dermatology, and served as chair for the 69th Annual Meeting of the American Academy of Dermatology. He is also a founding board member of the American Acne & Rosacea Society and is a founder and co-chair of the Pediatric Dermatology Research Alliance, a collaborative research network.
He has been named one of the "Best Doctors in America" since 1994.
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
Feinstein JA, Jambal P, Peoples K, Lucky AW, Khuu P, Tang JY, Lara-Corrales I, Pope E, Wiss K, Hook KP, Levin LE, Morel KD, Paller AS, McCuaig CC, Powell J, Eichenfield LF, Price H, Levy ML, Schachner LA, Browning JC, Bayliss S, Jahnke M, Shwayder T, Glick SA, Bruckner AL
Atopic Dermatitis: New Developments.
Kusari A, Han AM, Schairer D, Eichenfield LF
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families.
Simpson EL, Paller AS, Boguniewicz M, Eichenfield LF, Feldman SR, Silverberg JI, Chamlin SL, Zane LT
Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders.
Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, Tofte S, Dunn JD, Feldman SR, Clark AR, Schwartz G, Eichenfield LF
Treatment of Pediatric Treadmill Burn Contractures With Ablative Fractional Laser and Topical Triamcinolone Suspension.
Tu JH, Udkoff JA, Eichenfield LF
Primary cutaneous aspergillosis at the site of cyanoacrylate skin adhesive in a neonate.
Kusari A, Sprague J, Eichenfield LF, Matiz C, Barrio VR
Transforming acne care by pediatricians: An interventional cohort study.
Borok J, Udkoff J, Vaida F, Murphy J, Torriani F, Waldman A, Ahluwalia J, Eichenfield LF
Waldman AR, Ahluwalia J, Udkoff J, Borok JF, Eichenfield LF
Developing drugs for treatment of atopic dermatitis in children (â‰¥3 months to <18 years of age): Draft guidance for industry.
Siegfried EC, Jaworski JC, Eichenfield LF, Paller A, Hebert AA, Simpson EL, Altman E, Arena C, Blauvelt A, Block J, Boguniewicz M, Chen S, Cordoro K, Hanna D, Horii K, Hultsch T, Lee J, Leung DY, Lio P, Milner J, Omachi T, Schneider C, Schneider L, Sidbury R, Smith T, Sugarman J, Taha S, Tofte S, Tollefson M, Tom WL, West DP, Whitney L, Zane L
Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey.
Zeichner JA, Eichenfield LF, Feldman SR, Kasteler JS, Ferrusi IL
A Note from the Journal's Editors-in-Chief.
Frieden IJ, Eichenfield LF
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
Simpson EL, Flohr C, Eichenfield LF, Bieber T, Sofen H, TaÃ¯eb A, Owen R, Putnam W, Castro M, DeBusk K, Lin CY, Voulgari A, Yen K, Omachi TA
Pediatric psoriasis: Evolving perspectives.
Eichenfield LF, Paller AS, Tom WL, Sugarman J, Hebert AA, Friedlander SF, Siegfried E, Silverberg N, Cordoro KM
Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth viaÂ Cancer Genomics.
Siegel DH, Cottrell CE, Streicher JL, Schilter KF, Basel DG, Baselga E, Burrows PE, Ciliberto HM, Vigh-Conrad KA, Eichenfield LF, Holland KE, Hogeling M, Jensen JN, Kelly ME, Kim W, King DM, McCuaig C, Mueller KA, Pope E, Powell J, Price H, Steiner JE, Frieden IJ, Tollefson MM, Drolet BA
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.
Boguniewicz M, Alexis AF, Beck LA, Block J, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Lebwohl M
Atopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to care.
LeBovidge J, Borok J, Udkoff J, Yosipovitch G, Eichenfield LF
Atopic dermatitis: emerging therapies.
Simpson E, Udkoff J, Borok J, Tom W, Beck L, Eichenfield LF
Atopic dermatitis: skin care and topical therapies.
Fleischer DM, Udkoff J, Borok J, Friedman A, Nicol N, Bienstock J, Lio P, Tollefson MM, Eichenfield LF
Atopic dermatitis: pathogenesis.
Guttman-Yassky E, Waldman A, Ahluwalia J, Ong PY, Eichenfield LF
Curriculum United for Better Eczema Care: why, how, and what?
Eichenfield LF, Ahluwalia J, Davis DM, Fleischer DM, Waldman A, Spergel J
Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis.
Eichenfield LF, Call RS, Forsha DW, Fowler J Jr, Hebert AA, Spellman M, Stein Gold LF, Van Syoc M, Zane LT, Tschen E
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S, Deleuran M, Bieber T, Vestergaard C, Brown SJ, Cork MJ, Drucker AM, Eichenfield LF, Foelster-Holst R, Guttman-Yassky E, Nosbaum A, Reynolds NJ, Silverberg JI, Schmitt J, Seyger MMB, Spuls PI, Stalder JF, Su JC, Takaoka R, Traidl-Hoffmann C, Thyssen JP, van der Schaft J, Wollenberg A, Irvine AD, Paller AS
Highlights of Skin Disease Education Foundation's 41st Annual Hawaii Dermatology Seminarâ„¢.
Gordon KB, Leonardi CL, Furst DE, Bhatia N, Eichenfield LF, Beleznay K
See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.
PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.
Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at email@example.com.